3147 CSOP SZSE ChiNext ETF
ChiNext PR CNY

NAV as of 15-Aug-2019

6.2093

4 Week: 9.03 - 9.99

52 Week: 9.03 - 15.13

Latest Closing Price

9.55

Premium / Discount

0.54

Expense Ratio

1.28%

Investment Objective

The investment objective of the Sub-Fund is to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index, namely, ChiNext Index (the “Underlying Index”).

Main Fund Characteristics

Fund Manager:
CSOP Asset Management Limited
Asset Under Management:
489,643,680
Launch Date:
N.A
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
139
Trading Currency:
HKD
Style:
Large Growth
Region/Sector/Strategy:
N.A / N.A / N.A
Exchange:
HKEX

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-33.632.36-14.26
1 Day-3.780.000.00
1 Week-1.196.21-0.19
1 Month-1.5512.89-0.12
3 Months-20.8120.80-1.00
6 Months-36.3824.28-1.50
1 Year-28.8932.65-0.88
2 Years23.5447.930.49
3 Years64.6657.501.12
5 Years28.5370.320.41
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.0000-28.2087-13.1765-29.089042.745663.709711.3854
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.000098.000099.000092.000027.00003.00005.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 139

Number of Bond Holdings: 0

Number of Equity Holdings: 89

Total Market Value: 489,643,680

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Contemporary Amperex Technology Co Ltd Class A13.5964128,298-78,20066,573,832
2East Money Information Co-A (Funded Total Return S5.32841,000,0001,000,00026,090,000
3Contemporary Amperex Techn-A (Funded Total Return 5.298850,00050,00025,945,000
4Shenzhen Mindray Bio-Medic-A4.005464,10062,90019,612,036
5Wens Foodstuff Group Co Ltd Class A3.3012730,740-115,60016,163,969
6Sungrow Power Supply Co Lt-A (Funded Total Return 3.2329150,000015,829,500
7EVE Energy Co Ltd Class A3.1758190,843-29,60015,549,888
8Walvax Biotechnology Co-A (Funded Total Return Swa3.1113282,900015,234,165
9Chongqing Zhifei Biologica-A (Funded Total Return 3.0095110,000014,735,600
10Aier Eye Hospital Group Co-A (Funded Total Return 2.2938350,000011,231,500

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant24.15
Large22.18
Medium6.10
Small0.00
Micro0.00

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

34.1335

Price/Book*

5.2399

Price/Sales*

4.9296

Price/Cash Flow*

21.5331

Dividend Yield*

0.4959

Growth Measures

Long-Term Earnings

36.0960

Historical Earnings

15.9965

Sales Growth

16.8979

Cash-Flow Growth

2.1284

Book-Value Growth

20.1806

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.